Birinapant
Birinapant Uses, Dosage, Side Effects, Food Interaction and all others data.
Birinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).
| Trade Name | Birinapant |
| Generic | Birinapant |
| Birinapant Other Names | Birinapant |
| Type | |
| Formula | C42H56F2N8O6 |
| Weight | Average: 806.957 Monoisotopic: 806.429087881 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Birinapant
